"We realize it's important to bring together, through partnership and collaboration, diverse scientific talent and capabilities to find the best possible outcomes for the people we serve."
ALAN PALKOWITZ, PH.D.
Vice President, Discovery Chemistry
Research and Technologies

For Scientists.
By Scientists.

MAKING LIVES BETTER. TOGETHER.

The Lilly Open Innovation Drug Discovery (OIDD) Program is founded on the belief that pharmaceutical companies, research institutions and academia share a mutual desire to advance innovative biomedical science. OIDD is a premier collaborative platform that unites global investigators with Lilly scientists to both uncover and create innovation that may positively impact the people we serve. Read more in the OIDD Brochure.

DESIGN
Cheminformatics tools for designing molecules with desirable drug-like properties or suited to a particular biological target. MORE >
SCREENING
Biological screening of your compounds in areas of strategic interest to Lilly. All results generated are available to you via the OIDD platform. MORE >
COMPOUND
ACQUISITION
Opportunity to have your compounds selected for inclusion into Lilly's compound collection using structural diversity tools. MORE >
SYNTHESIS
Access to the Lilly Automated Synthesis Laboratory, to explore new chemistry. MORE >
NEGLECTED
& TROPICAL
DISEASES
Opportunities to work with non-profit, public-private partnerships to contribute to early-stage drug discovery for unmet medical needs. MORE >